gene therapy sarepta - Search News

Order byBest matchMost fresh

News

Sarepta, The Revell

· 22h · on MSN

Sarepta fails to win EU backing for muscle disorder gene therapy

Sarepta Therapeutics failed to win the European drug regulator's backing for its muscle disorder gene therapy on Friday, as the company faces intense regulatory scrutiny after two recent patient deaths tied to the treatment.

Continue reading

· 6h · on MSN

What’s behind Sarepta’s gene therapy deaths?

· 10h · on MSN

Two boys died after a gene therapy. This family won’t give up hope.

3h

FDA opens probe into mysterious death linked to gene therapy

The Food & Drug Administration is investigating the death of an 8‑year‑old following Elevidys gene therapy for Duchenne ...

Fierce Pharma2d

FDA weighs new study requirements for Sarepta to confirm safety of gene therapy Elevidys: report

Sarepta would need to conduct new analyses to validate the safety of Elevidys—which has had U.S. shipments paused by the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results